PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway
Environmental Toxicology · 2024
DOI: 10.1002/tox.23872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Dongtao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China; Department of Oncological Surgery, Baotou Central Hospita…. Hauptthemen laut MEDLINE: Signal Transduction, Thyroid Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: The Inner Mongolia Autonomous Region Science and Technology Innovation Guidance Project, Tianjin Education Commission Scientific Research Project.
Abstract (Originalsprache)
Thyroid cancer is the most common endocrine malignancy worldwide. Although significant progress has been made in understanding the genetic and molecular alterations that drive thyroid cancer, the mechanisms underlying thyroid tumor progression remain unclear. In this study, we explored the involvement of Plastin‐3 (PLS3) in the progression of papillary thyroid cancer and elucidated the underlying molecular mechanisms. We first analyzed clinical samples from papillary thyroid cancer patients and found that PLS3 expression was significantly upregulated in tumor tissues compared to adjacent normal tissues. Moreover, high PLS3 expression was associated with advanced tumor stage and poor prognosis. Further in vitro and in vivo experiments showed that PLS3 could promote the proliferation, migration, and invasive behavior of papillary thyroid cancer cells, while PLS3 knockdown suppressed these processes. Mechanistically, we found that PLS3 promoted papillary thyroid cancer progression by activating the Notch signaling pathway. Specifically, PLS3 upregulated the expression of Notch receptors (Notch1) and downstream target gene (Hes1) in papillary thyroid cancer cells. In summary, our findings collectively indicate that PLS3 plays a pivotal role in driving the progression of papillary thyroid cancer and holds promise as a viable therapeutic target for the treatment of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China; Department of Oncological Surgery, Baotou Central Hospital, Baotou, Inner Mongolia, China.
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China;, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China.
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China;, Huai'an Second People's Hospital, Huai'an, Jiangsu, China.
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Dongtao Wang
Förderung
- The Inner Mongolia Autonomous Region Science and Technology Innovation Guidance Project
- Tianjin Education Commission Scientific Research Project
Zitieren
APA
Wang, D., Liu, J., Chen, Y., Jia, L., Zhao, K., & He, X. (2024). PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway. Environmental Toxicology. https://doi.org/10.1002/tox.23872
Vancouver
Wang D, Liu J, Chen Y, Jia L, Zhao K, He X. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway. Environmental Toxicology. 2024. doi:10.1002/tox.23872
BibTeX
@article{Wang2024,
author = {Wang, Dongtao and Liu, Jingping and Chen, Yong and Jia, Lanning and Zhao, Ke and He, Xianghui},
title = {PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.23872}
}
EUVIMED